TG Therapeutics, Inc. (TGTX): Price and Financial Metrics

TGTX POWR Grades

• Growth is the dimension where TGTX ranks best; there it ranks ahead of 55.45% of US stocks.
• The strongest trend for TGTX is in Momentum, which has been heading down over the past 47 weeks.
• TGTX's current lowest rank is in the Stability metric (where it is better than 9.93% of US stocks).

TGTX Stock Summary

• Tg Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 6.51% of US listed stocks.
• TGTX's price/sales ratio is 1,779.78; that's higher than the P/S ratio of 99.54% of US stocks.
• Revenue growth over the past 12 months for Tg Therapeutics Inc comes in at 1,488.16%, a number that bests 99.16% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to Tg Therapeutics Inc are DNLI, BPMC, DCPH, RYTM, and FIXX.
• Visit TGTX's SEC page to see the company's official filings. To visit the company's web site, go to www.tgtherapeutics.com.

TGTX Valuation Summary

• In comparison to the median Healthcare stock, TGTX's price/sales ratio is 42050% higher, now standing at 1601.7.
• TGTX's price/earnings ratio has moved down 7.9 over the prior 138 months.
• TGTX's EV/EBIT ratio has moved down 5.4 over the prior 138 months.

Below are key valuation metrics over time for TGTX.

TGTX Growth Metrics

• Its 4 year net cashflow from operations growth rate is now at -207.86%.
• Its 5 year price growth rate is now at 48.46%.
• The 4 year price growth rate now stands at 157.91%.

TGTX's revenue has moved up $2,261,619 over the prior 70 months.

The table below shows TGTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	2.414	-250.082	-344.506
2021-03-31	0.907	-233.747	-318.893
2020-12-31	0.152	-214.507	-279.381
2020-09-30	0.152	-192.874	-230.735
2020-06-30	0.152	-169.544	-205.502
2020-03-31	0.152	-161.57	-188.831

TGTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• TGTX has a Quality Grade of D, ranking ahead of 21.92% of graded US stocks.
• TGTX's asset turnover comes in at 0.005 -- ranking 409th of 677 Pharmaceutical Products stocks.
• TMBR, ATRA, and QURE are the stocks whose asset turnover ratios are most correlated with TGTX.

The table below shows TGTX's key quality metrics over time.